What is the current Price Target for the Mereo BioPharma Group plc Sponsored ADR stock?

The average Mereo BioPharma Group plc Sponsored ADR target price is $7.30. This is 208.02% higher than the current stock price. The highest price target is 321.94%, the lowest is 140.51%. 9 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2026 .

How high will the Mereo BioPharma Group plc Sponsored ADR stock rise?

No reliable answer can be given as to how high the Mereo BioPharma Group plc Sponsored ADR stock will rise. The performance of stocks, including the Mereo BioPharma Group plc Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Mereo BioPharma Group plc Sponsored ADR stock today?

The performance of Mereo BioPharma Group plc Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Mereo BioPharma Group plc Sponsored ADR stock fall?

The decline in Mereo BioPharma Group plc Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mereo BioPharma Group plc Sponsored ADR Forecast, price target & analysts

$2.28

4.01% today

Nasdaq, Apr 03, 07:14 pm CET

ISIN

US5894921072

Symbol

MREO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Mereo BioPharma Group plc Sponsored ADR Target price 2025 - Analyst rating & recommendation

Mereo BioPharma Group plc Sponsored ADR Classifications & Recommendation:

Buy

100%

Mereo BioPharma Group plc Sponsored ADR Price Target

Target Price	$7.30
Price	$2.37
Potential	208.02% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2026 . The average Mereo BioPharma Group plc Sponsored ADR target price is $7.30. This is 208.02% register free of charge higher than the current stock price. The highest price target is $10.00 321.94% register free of charge , the lowest is $5.70 140.51% register free of charge .
	A rating was issued by 9 analysts: 9 Analysts recommend Mereo BioPharma Group plc Sponsored ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mereo BioPharma Group plc Sponsored ADR stock has an average upside potential 2026 of 208.02% register free of charge . Most analysts recommend the Mereo BioPharma Group plc Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.29	-0.08
	45.00%	72.41%
P/E		negative
EV/Sales		8.02

3 Analysts have issued a Mereo BioPharma Group plc Sponsored ADR forecast for earnings per share. The average Mereo BioPharma Group plc Sponsored ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.29	45.00%
2025	$-0.08 72.41% Unlock
2026	$-0.01 87.50% Unlock
2027	$-0.07 600.00% Unlock
2028	$-0.03 57.14% Unlock
2029	$0.04 233.33% Unlock

Current	-8.08	38.79%
2025	-28.44 251.98% Unlock
2026	-237.00 733.33% Unlock
2027	-36.46 84.62% Unlock
2028	-79.00 116.68% Unlock
2029	59.25 175.00% Unlock

Mereo BioPharma Group plc Sponsored ADR...

Current Mereo BioPharma Group plc Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Mar 27 2025
Needham	Locked ➜ Locked	Locked	Mar 26 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Mar 18 2025
Needham	Locked ➜ Locked	Locked	Jan 13 2025
LifeSci Capital	Locked ➜ Locked	Locked	Dec 24 2024
Jefferies	Locked ➜ Locked	Locked	Dec 06 2024
Needham	Locked ➜ Locked	Locked	Nov 12 2024

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Mar 27 2025
Locked Needham: Locked ➜ Locked	Mar 26 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Mar 18 2025
Locked Needham: Locked ➜ Locked	Jan 13 2025
Locked LifeSci Capital: Locked ➜ Locked	Dec 24 2024
Locked Jefferies: Locked ➜ Locked	Dec 06 2024
Locked Needham: Locked ➜ Locked	Nov 12 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now